Edward Barnes
University of North Carolina, Chapel Hill · University of North Carolina
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Edward Barnes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:15 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07756359 · Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)University of North Carolina, Chapel Hill · not yet recruiting · Pouch, Ileal, Pouches, Ileoanal, Bowel Diseases, Inflammatory · principal investigator
- Ph4NCT06864403 · Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the PouchUniversity of North Carolina, Chapel Hill · active not recruiting · Pouchitis, Pouches, Ileoanal, Pouch, Ileal · principal investigator
- Ph4NCT06312683 · Rifaximin for the Secondary Prevention of Recurrent PouchitisUniversity of North Carolina, Chapel Hill · recruiting · Pouchitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Secondary Prevention of Pouchitis With RifaximinR03DK140415 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2025 · $250,056 awarded in 2025Grant number is on one of their registry trials
- Treatment Approaches and Outcomes in Pouch-related Disorders after Colectomy for Ulcerative ColitisK23DK127157 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2021 to 2025 · $200,052 awarded in 2025Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:15 UTC. The ranking covers the 200 most relevant of 63 PubMed records, and a shared surname and initials can bring in a namesake. All 63 on PubMed
- 442 citationsRCR 17.3
- A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.Sci Transl Med · 2014286 citationsRCR 7.6
- Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus.Circulation · 2016221 citationsRCR 8.6
- 212 citationsRCR 9.5
- 190 citationsRCR 7.0
- 176 citationsRCR 18.8
- A randomized trial of egg introduction from 4 months of age in infants at risk for egg allergy.J Allergy Clin Immunol · 2017149 citationsRCR 7.3
- Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.J Clin Oncol · 2003137 citationsRCR 4.2
- Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.Neuro Oncol · 2015127 citationsRCR 4.2
- Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.Arterioscler Thromb Vasc Biol · 2013116 citationsRCR 3.7